Rituximab is typically administered via intravenous (IV) infusion. The dosage and schedule depend on the specific type of cancer being treated, the patient's overall health, and other factors. Infusion times can vary, and premedication with acetaminophen, antihistamines, or corticosteroids may be given to reduce the risk of infusion reactions.